Replies to post #2999 on BioCryst Pharmaceuticals,Inc. (BCRX)

[Deano361]

Well the analyst currently are $5-13 range with an average just over $8 I believe so could be nice!!! Analyst/Stocks typically price pre-revenue movement so $10-13 seems to be right number on HAE alone. Depends on multiple in market. As CRACKME always says, it's a buyout potential candidate as well and well in the drug space they pay multiples of future revenue, not EBITDA since there is none at these early stages. That is why I always say $20 exit price for BioCryst to sell solely based on current pipeline of drugs and solely based on their current phases. $20 is a $4B price on half the A/S. We shall see what the market brings.